Proprotein convertases in tumor progression and malignancy: Novel targets in cancer therapy

American Journal of Pathology

Volumn 160, Issue 6, 2002, Pages 1921-1935

  Khatib, Abdel Majid ^a   Siegfried, Géraldine ^a   Chrétien, Michel ^b   Metrakos, Peter ^c   Seidah, Nabil G ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 1 ANTITRYPSIN PORTLAND; ANTINEOPLASTIC AGENT; CELL ADHESION MOLECULE; ENZYME; ENZYME INHIBITOR; ENZYME VARIANT; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN; INTEGRIN; KEXIN; MATRIX METALLOPROTEINASE; PROPROTEIN CONVERTASE; PROPROTEIN CONVERTASE INHIBITOR; PROTEIN PRECURSOR; SELECTIN; STROMELYSIN 3; SUBTILISIN; SYNTHETIC PEPTIDE; THROMBOSPONDIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; CANCER THERAPY; CARCINOGENESIS; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; TUMOR GROWTH; UNINDEXED SEQUENCE;

EID: 0036083664     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61140-6     Document Type: Review

References (171)

1. Proprotein and prohormone convertases: A family of subtilases generating diverse bioactive polypeptides
2. Eukaryotic protein processing: Endoproteolysis of precursor proteins
3. Furin: A mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins
4. Proteolytic processing in the secretory pathway
5. The family of subtilisin/kexin like pro-protein and pro-hormone convertases: Divergent or shared functions
6. Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization
7. Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells
8. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs
9. The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P
10. Carboxypeptidases from A to Z: Implications in embryonic development and Wnt binding
11. From proopiomelanocortin to cancer: Possible role of convertases in neoplasia
12. Expression of the prohormone convertase PC2 correlates with the presence of corticotropin-like intermediate lobe peptide in human adrenocorticotropin-secreting tumors
13. Inhibition of processing of parathyroid hormone-related peptide by anti-sense furin: Effect in vitro and in vivo on rat Leydig (H-500) tumor cells
14. Proprotein convertases and the pathophysiology of human diseases: Prospective considerations
15. Proprotein-processing endoprotease furin controls the growth and differentiation of gastric surface mucous cells
16. Proprotein-processing endoprotease furin controls growth of pancreatic beta-cells
17. Expression of PACE4 in chemically induced carcinomas is associated with spindle cell tumor conversion and increased invasive ability
18. The proprotein convertases furin and PACE4 play a significant role in tumor progression
19. Elevated expression of proprotein convertases alters breast cancer cell growth in response to estrogen and tamoxifen
20. Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: Importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions
21. Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells
22. Processing of immunosuppressive pro-TGF-beta-1,2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases
23. Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours
24. Pro-protein convertase gene expression in human breast cancer
25. Elevated furin expression in aggressive human head and neck tumors and tumor cell lines
26. Localization of prohormone convertases 1/3 and 2 in the human pituitary gland and pituitary adenomas: Analysis by Immunohistochemistry, immunoelectron microscopy, and laser scanning microscopy
27. Distribution and regulation of proconvertases PC1 and PC2 in human pituitary adenomas
28. Immunohisto-chemical expressions of prohormone convertase (PC)1/3 and PC2 in carcinoids of various organs
29. Pro-neurotensin/neuromedin N expression and processing in human colon cancer cell lines
30. Prohormone convertase 2 is necessary for the formation of cholecystokinin but not cholecystokinin-8, in RIN5F and STC-1 cells
31. Somatostatin-14, somatostatin-28, and prosomatostatin[1-10] are independently and efficiently processed from prosomatostatin in the constitutive secretory pathway in islet somatostatin tumor cells (1027B2)
32. Evidence that PC2 is the endogenous pro-neurotensin convertase in rMTC 6-23 cells and that PC1-and PC2-transfected PC12 cells differentially process pro-neurotensin
33. Cellular distributions of the prohormone processing enzymes PC1 and PC2
34. Prohormone convertases (PC1/3 and PC2) in rat and human pancreas and islet cell tumors: Subcellular immunohistochemical analysis
35. The differential processing of proenkephalin A in mouse and human breast tumour cell lines
36. Key peptide processing enzymes are expressed by breast cancer cells
37. Prohormone convertase and autocrine growth factor mRNAs are coexpressed in small cell lung carcinoma
38. Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmeric acetate and furin-type convertases
39. Furin-dependent intracellular activation of the human stromelysin-3 zymogen
40. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases
41. Human ADAM 12 (meltrin α) is an active metalloprotease
42. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene
43. ADAMTS-1 is an active metalloproteinase associated with the extracellular matrix
44. Membrane-type 1 matrix metalloproteinase mRNA expression in colorectal cancer
45. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor
46. The ADAM gene family: Surface proteins with adhesion and protease activity
47. Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies
48. The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone
49. Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member
50. Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer
51. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors
52. Invasiveness of hepatocellular carcinoma cell lines: Contribution of membrane-type 1 matrix metalloproteinase
53. Metalloprotease-disintegrins: Modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding
54. ADAMs: Focus on the protease domain
55. ADAMs in fertilization and development
56. Purification of ADAM 10 from bovine spleen as a TNFα convertase
57. Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein
58. Interaction of metargidin (ADAM-15) with alphavbeta3 and alpha5beta1 integrins on different haemopoietic cells
59. Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: Involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10
60. Evidence that distinct states of the integrin alpha6beta1 interact with laminin and an ADAM
61. RGD-independent binding of integrin alpha 9beta 1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction
62. Cysteine-rich domain of human ADAM 12 (meltrin) supports tumor cell adhesion
63. Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells
64. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage
65. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family
66. Gene expression profiling in an in vitro model of angiogenesis
67. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration
68. Leukocyte-endothelial adhesion molecules
69. Regulation of endothelial cell function by pro- and anti-inflammatory cytokines
70. The role of endothelial cells in inflammation
71. Insulin like growth factor-1 activates nuclear factor-kappaB and increases transcription of the intercellular adhesion molecule-1 gene in endothelial cells
72. Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor α-stimulated vascular endothelial cells
73. ICAM-1 expression on cardiac myocytes and aortic endothelial cells via their specific endothelin receptor subtype 1
74. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells
75. Platelet-derived growth factor is a potent stimulator of expression of intercellular adhesion molecule-1 in human arterial smooth muscle cells
76. VEGF stimulates expression of ICAM-1, VCAM-1 and E-selectin through nuclear factor-kappaB activation in endothelial cells
77. Mutational analysis of the insulin-like growth factor I prohormone processing site
78. Processing of proendothelin-1 by human furin convertase
79. Schlöndorff Metalloprotease-disintegrins: Modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding
80. ADAMs: Focus on the protease domain
81. Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases
82. Adhesion molecules in tumor metastasis
83. Role of integrins and other cell adhesion molecules in tumor progression and metastasis
84. Signal transduction from the extracellular matrix
85. Integrin-mediated adhesion and signaling in tumorigenesis
86. Expression of the v-crk oncogene prqduct in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways
87. Anti-β4 integrin antibodies enhance migratory and invasive abilities of human colon adenocarcinoma cells and their MMP-2 expression
88. Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor αvβ3
89. Lack of integrin α-chain endoproteolytic cleavage in furin-deficient human colon adenocarcinoma cells LoVo
90. Endoproteolytic processing of integrin pro-α subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7
91. Role of endoproteolytic processing in the adhesive and signaling functions of αvβ5 integrin
92. Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: Liver colonization and adhesion to vascular endothelial cells
93. E-selectin-mediated dynamic interactions of breast- and coloncancer cells with endothelial-cell monolayers
94. Selectins: Selectins
95. An endothelial ligand for L-selectin is a novel mucin-like molecule
96. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium
97. Importance of E-selectin (ELAM-1) and sialyl Lewis(a) in the adhesion of pancreatic carcinoma cells to activated endothelium
98. Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin
99. Cytokine-activated endothelial cells internalize E-selectin into a lysosomal compartment of vesiculotubular shape. A tubulin-driven process
100. Cell adhesion molecules and insulin-like growth factor-1 in vascular disease
101. Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells
102. G1 events and regulation of cell proliferation
103. Cell cycle and growth control
104. Oncogenic activation of tyrosine kinases
105. Vascular endothelial growth factor promotes cell-cycle transition from GO to G1 phase in subcultured endothelial cells of diabetic rat thoracic aorta
106. Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-β-NGF in vivo
107. Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases
108. Proparathyroid hormone is preferentially cleaved to parathyroid hormone by the prohormone convertase furin: A mass spectrometric study
109. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
110. Growth factor receptor tyrosine kinases
111. Association of the multisubstrate docking protein Gab1 with the hepatocyte growth factor receptor requires a functional Grb2 binding site involving tyrosine 1356
112. Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro
113. PDGF induction of tyrosine phosphorylation of GTPase activating protein
114. Common elements in growth factor stimulation and oncogenic transformation: 85 kda phosphoprotein and phosphatidylinositol kinase activity
115. The IRS-signaling system: A network of docking proteins that mediate insulin and cytokine action
116. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
117. Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness
118. Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells
119. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase
120. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression
121. Expression of the HGF/SF cancers
122. Proteolytic processing of the hepatocyte growth factor/scatter factor receptor by furin
123. Elevated insulin receptor content in human breast cancer
124. Defective processing of the insulin receptor in an endoprotease-deficient Chinese hamster cell strain is corrected by expression of mouse furin
125. Alternative glycosylation of the insulin receptor prevents oligomerization and acquisition of insulin-dependent tyrosine kinase activity
126. Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor beta subunit
127. Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed α 1-antitrypsin variant
128. α1-antitrypsin Portland, a bioengineered serpin highly selective for furin: Application as an antipathogenic agent
129. The prosegments of furin and PC7 as potent inhibitors of proprotein convertases: In vitro and ex vivo assessment of their specificity and selectivity
130. Inhibitory activity and structural characterization of a C-terminal peptide fragment derived from the prosegment of the proprotein convertase PC7
131. Crystal structure of the complex of subtilisin BPN' with its protein inhibitor Streptomyces subtilisin inhibitor. The structure at 4.3 Angstroms resolution
132. Arg15-Lys17-Arg18 turkey ovomucoid third domain inhibits human furin
133. Serpin-like properties of alpha1-antitrypsin Portland towards furin convertase
134. Inhibition of intracellular proteolytic processing of soluble proproteins by an engineered alpha 2-macroglobulin containing a furin recognition sequence in the bait region
135. Inhibition of soluble recombinant furin by human proteinase inhibitor 8
136. Polyarginines are potent furin inhibitors
137. Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases
138. α1-antitrypsin Portland inhibits processing of precursors mediated by pro-protein convertases primarily within the constitutive secretory pathway
139. Effect of alpha-1 antitrypsin Portland variant (α1-PDX) on HIV-1 replication
140. Inactivation of proprotein convertase, PACE4, by α1-antitrypsin Portland (α1-PDX), a blocker of proteolytic activation of bone morphogenetic protein during embryogenesis: Evidence that PACE4 is able to form an SDS-stable acyl intermediate with α1-PDX
141. Proprotein convertase activity contributes to the processing of the Alzheimer's β-amyloid precursor protein in human cells: Evidence for a role of the prohormone convertase PC7 in the constitutive α-secretase pathway
142. The pore-forming toxin proaerolysin is activated by furin
143. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development
144. The Notch1 receptor is cleaved constitutively by a furin-like convertase
145. Evidence that furin is an authentic transforming growth factor β1-converting enzyme
146. Processing of transforming growth factor beta 1 precursor by human furin convertase
147. Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis
148. Post-translational processing of insulin-like growth factor
149. A Kex2-related endopeptidase activity present in rat liver specifically processes the insulin proreceptor
150. Increased proteolytic processing of protein tyrosine phosphatase mu in confluent vascular endothelial cells: The role of PC5, a member of the subtilisin family
151. The IGF-I receptor in cancer research
152. Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF-II-mediated autocrine loop
153. Fibronectin and its integrin receptors in cancer
154. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis
155. PI3K: Downstream AKTion blocks apoptosis
156. Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function
157. Anti-apoptotic versus proapoptotic signal transduction: Checkpoints and stop signs along the road to death
158. Cellular limited proteolysis of precursor proteins and peptides
159. Two activation states of the prohormone convertase PC1 in the secretory pathway
160. Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing
161. Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1
162. Neuroendocrine secretory protein 7B2: Structure, expression and functions
163. Intramolecular chaperones and protein folding
164. The propeptide of preprosomatostatin mediates intracellular transport and secretion of alpha-globin from mammalian cells
165. Activation of the furin endoprotease is a multiple-step process: Requirements for acidification and internal propeptide cleavage
166. Proprotein convertase PC1/3-related peptides are potent slow tight-binding inhibitors of murine PC1/3 and Hfurin
167. In vitro cleavage of internally quenched fluorogenic human proparathyroid hormone and proparathyroid-related peptide substrates by furin. Generation of a potent inhibitor
168. Post-translational processing of beta-secretase (betaamyloid-converting enzyme) and its ectodomain shedding. The proand transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production
169. Trophic factors and central nervous system metastasis
170. Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1
171. Neuroendocrine secretory proein 7B2: Structure, expression and functions